Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. DOL:CN
9. NDAQ
10. CRM

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET

Enanta Pharma (ENTA) Reports In-Line Q4 EPS

November 22, 2021 4:02 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($1.22), in-line with the analyst estimate of ($1.22). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $26.34 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More